The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.42
Bid: 17.42
Ask: 18.08
Change: 0.14 (0.80%)
Spread: 0.66 (3.789%)
Open: 17.42
High: 17.42
Low: 17.42
Prev. Close: 17.61
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM, Move to Main Market and Placing

22 Apr 2015 16:45

RNS Number : 0446L
Nanoco Group PLC
22 April 2015
 

 

For immediate release

22 April 2015

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Result of General Meeting, Move to Main Market

and Placing to raise £20 million gross

 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that all resolutions were duly passed at its General Meeting held earlier today in connection with the Company's proposed move from AIM to the Main Market of the London Stock Exchange and the Placing announced on 31 March 2015.

 

Following the outcome of the General Meeting, the Company will now proceed with the proposed move to the Main Market and the Placing to raise gross proceeds of £20 million.

A summary of the votes cast on the Resolutions put to Shareholders at the General Meeting is shown below:

 

Resolutions

For

Against

Withheld

Number

%

Number

%

Number

1

THAT, conditionally upon Admission, the New Articles of Association (as defined in the Circular) be approved and adopted as the new articles of association of the Company in substitution for, and to the exclusion of, the existing articles of association of the Company.

 

140,776,175

 

99.95

72,957

0.05

578

2

THAT, conditionally upon the passing of Resolution 1 and in addition to the authority conferred on the Directors at the annual general meeting of the Company held on 11 December 2014, the Directors be generally and unconditionally authorised, in accordance with section 551 of the Companies Act 2006, to allot up to 19,047,619 Ordinary Shares in aggregate in the capital of the Company, such authority to expire at the end of 31 July 2015.

 

140,776,753

 

99.94

80,400

0.06

0

3

THAT, conditionally upon the passing of Resolutions 1 and 2 and in addition to the authority conferred on the Directors at the annual general meeting of the Company held on 11 December 2014, the Directors be given power to allot up to 19,047,619 Ordinary Shares for cash pursuant to the authority referred to in Resolution 2 other than on a pro-rata basis to shareholders as if section 561 of the Companies Act 2006 did not apply, such authority to expire at the end of 31 July 2015.

 

140,761,553

 

99.86

 

201,664

0.14

15,200

 

The issued share capital of the Company on the date of the meeting was 217,330,383 ordinary shares of 10 pence each ("Ordinary Shares").

In accordance with the Disclosure Rules and Transparency Rules, a copy of the Resolutions proposed and passed at the General Meeting will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM and will also be available for inspection at www.nanocotechnologies.com.

Notification of the Company's intention to de-list from AIM has been submitted to the London Stock Exchange. It is expected that the last day of dealings in the Ordinary Shares on AIM will occur on 30 April 2015.

Applications will shortly be made to the Official List and to the London Stock Exchange for 236,378,002 Ordinary Shares, fully paid and conditional upon Admission, to be admitted to listing on the premium segment of the Official List and to be admitted to trading on the Main Market. It is expected that Admission of the 236,378,002 Ordinary Shares will occur at 8.00 a.m. on 1 May 2015.

Completion of the Placing and Admission remains subject to certain conditions. A further announcement will be made in due course.

All capitalised terms in this announcement have the meaning given to them in the Circular, unless otherwise defined herein.

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Mark Sullivan, Interim Chief Financial Officer

Canaccord Genuity - Nomad, Sponsor and Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Simon Atkinson

Richard Bootle

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUOVRVKASUAR
Date   Source Headline
23rd Aug 20222:22 pmRNSFunded Law Suit Filed in Germany
19th Aug 20228:21 amRNSLitigation Update – Pre-Trial Conference
18th Aug 20224:10 pmRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSTrading Update
28th Jul 202210:42 amRNSHolding(s) in Company
13th Jul 20222:03 pmRNSReplacement - Director/PDMR Shareholding
13th Jul 202212:00 pmRNSHolding(s) in Company
13th Jul 202212:00 pmRNSDirector/PDMR Shareholding
13th Jul 202212:00 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSTotal Voting Rights
29th Jun 20227:00 amRNSChange of Auditor
23rd Jun 20223:48 pmRNSDirector/PDMR Shareholding
22nd Jun 20222:25 pmRNSHolding(s) in Company
21st Jun 20223:36 pmRNSDirector/PDMR Shareholding
21st Jun 20229:06 amRNSReplacement: Director/PDMR Shareholding
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
17th Jun 20224:36 pmRNSPrice Monitoring Extension
17th Jun 202210:45 amRNSHolding(s) in Company
14th Jun 20229:42 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSBlock listing Six-monthly Return
8th Jun 202212:00 pmRNSResults of Fundraise
8th Jun 20227:00 amRNSFundraise significantly over-subscribed
7th Jun 20225:16 pmRNSReplacement: Litigation Update
7th Jun 20224:55 pmRNSLitigation Update
6th Jun 20227:02 amRNSTrading Update & Proposed Fundraise
6th Jun 20227:00 amRNSMajor Work Package for European Customer
23rd May 20225:00 pmRNSHolding(s) in Company
17th May 20227:02 amRNSLitigation Update
13th May 202212:15 pmRNSHolding(s) in Company
13th Apr 20222:49 pmRNSHolding(s) in Company
12th Apr 20227:00 amRNSInterim Results
17th Mar 20227:00 amRNSAdditional Work Package for European Customer
15th Mar 20227:00 amRNSNotice of Interim Results
4th Feb 20223:14 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSTotal Voting Rights
9th Dec 20217:00 amRNSBlock listing Six-Monthly Return
2nd Dec 20217:18 amRNSBlock Listing Application
1st Dec 202112:30 pmRNSDirector/PDMR Shareholding
1st Dec 202112:28 pmRNSAnnual General Meeting – Voting Results
30th Nov 20217:00 amRNSAGM Statement
18th Nov 20211:13 pmRNSDirector/PDMR Shareholding
9th Nov 20217:11 amRNSDirector/PDMR Shareholding
8th Nov 20217:00 amRNSDirector Appointment
5th Nov 202111:25 amRNSAdditional Work Package for European Customer
4th Nov 20216:20 pmRNSNotice of AGM
3rd Nov 20217:00 amRNSPreliminary Results
18th Oct 20216:10 pmRNSChange to final results announcement date
13th Oct 20219:30 amRNSPresentation via Investor Meet Company
8th Oct 20211:48 pmRNSNotice of Results
19th Aug 20217:00 amRNSNon-Executive Director Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.